Rainer Schwerdtfeger
Rainer Schwerdtfeger publishes mostly in Hematology, Genetics and Public Health, Environmental and Occupational Health, on topics such as Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research and Chronic Myeloid Leukemia Treatments.
- World rank
- #501,339 of 7,710,434 ranked researchers
- Rank in Germany
- #24,675 of 364,343
- Works
- 255
- Citations
- 12k
- Citations per work
- 46.2
What does Rainer Schwerdtfeger research?
Rainer Schwerdtfeger's work is mostly in Medicine (71%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences18271.2%
- Medicine18271.2%
- Everything else5822.7%
- Life Sciences166.1%
- 1Hematology45% of their works
- 2Genetics9% of their works
- 3Public Health, Environmental and Occupational Health7% of their works
- 4Immunology6% of their works
- 5Oncology6% of their works
- 6Epidemiology4% of their works
Research topics
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
- Multiple Myeloma Research and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Neutropenia and Cancer Infections
Which keywords describe Rainer Schwerdtfeger's research?
The keywords of their largest research topics: Hematopoietic Stem Cells, Prognostic Factors, Bone Marrow Niche, Graft-versus-Host Disease, Acute Myeloid Leukemia, AML, Minimal Residual Disease and BCR-ABL.
- JAK2 Mutation
- Antimicrobial Agents
- Diagnosis Criteria
- Chronic Lymphocytic Leukemia
- Acute Lymphoblastic Leukemia
- BCR-ABL
- Acute Myeloid Leukemia
- Graft-versus-Host Disease
- Prognostic Factors
- Hematopoietic Stem Cells
- Bone Marrow Niche
- AML
- Minimal Residual Disease
- Imatinib
- Childhood Cancer
- Genomic Aberrations
- International Myeloma Working Group
- Febrile Neutropenia
- Myelofibrosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Hematopoietic Stem Cells2232 topics
- Prognostic Factors1723 topics
- Bone Marrow Niche1311 topic
- Graft-versus-Host Disease1311 topic
- AML921 topic
- Acute Myeloid Leukemia921 topic
- Minimal Residual Disease702 topics
- BCR-ABL681 topic
- Imatinib681 topic
- Acute Lymphoblastic Leukemia451 topic
- Childhood Cancer451 topic
- Chronic Lymphocytic Leukemia351 topic
- Genomic Aberrations351 topic
- Diagnosis Criteria251 topic
- International Myeloma Working Group251 topic
- Antimicrobial Agents161 topic
- Febrile Neutropenia161 topic
- JAK2 Mutation161 topic
- Myelofibrosis161 topic
Where does Rainer Schwerdtfeger work?
Rainer Schwerdtfeger's main affiliation in the publication record is Deutsche Klinik für Diagnostik, Germany.
How many publications and citations does Rainer Schwerdtfeger have?
OpenAlex counts 255 works and 11,775 citations for Rainer Schwerdtfeger, an h-index of 55, ranking #501,339 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rainer Schwerdtfeger. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.